Brightpoint Asset Pty Ltd

Status: Registered
Australian Company Number: 126073327
Australian Business Number: 72126073327
Registration date: Wednesday 20th June 2007
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Brightpoint Asset Pty Ltd is a limited by shares Australian proprietary company. Located at WA 6021 since 2017-11-06 the company is, as the updated on 2017-11-06 ABN database shows, registered. Known company numbers for Brightpoint Asset Pty Ltd are as follows: ACN - 126073327, Australian Business Number - 72126073327. This Australian proprietary company was previously located in WA 6017 (from 2014-09-23 to 2017-11-06), WA 6017 (from 2014-01-18 to 2014-09-23), WA 6017 (from 2007-07-09 to 2014-01-18).

Advertisements

Details for ABN 72126073327

Type: Australian Private Company

ABN Status

Status From To
Active Monday 9th July 2007 current

Main Name

Name From To
Brightpoint Asset Pty Ltd Monday 9th July 2007 current

Main Location

Location From To
WA 6021 Monday 6th November 2017 current
WA 6017 Tuesday 23rd September 2014 Monday 6th November 2017
WA 6017 Saturday 18th January 2014 Tuesday 23rd September 2014
WA 6017 Monday 9th July 2007 Saturday 18th January 2014

Advertisements

Find company

WA 6021 Location

2018 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2018 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2018, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.